Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT06492915 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06492915
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-13
- Primary completion
- 2026-05-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.